A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.
- Status
- TERMINATED
- Phase
- PHASE2
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Derazantinib and Atezolizumab in Patients With Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Application of UCAD for Diagnosing Urothelial Carcinoma.
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)
- Status
- COMPLETED
- Phase
- PHASE3
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1